Aisen P. S., Gauthier S., Ferris S. H., Saumier D., Haine D., Garceau D., Duong A., Suhy J., Oh J., Lau W. C., Sampalis J. (2011). Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study), Arch Med Sci, 7(1), 102-11. En savoir plus.

Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. (2011). Alzheimer's disease, Lancet, 377(9770), 1019-1031. En savoir plus.

Belleville S., Clement F., Mellah S., Gilbert B., Fontaine F., Gauthier S. (2011). Training-related brain plasticity in subjects at risk of developing Alzheimer's disease, Brain, 134(Pt 6), 1623-1634. En savoir plus.

Gauthier S. (2011). Treatment of Alzheimer disease: the past, the present, and the future, Can J Psychiatry, 56(10), 577-578. En savoir plus.

Gauthier S., Patterson C., Gordon M., Soucy J.P., Schubert F., Leuzy A. (2011). Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective, Alzheimers Dement, 7(3), 330-332. En savoir plus.

Gauthier S., Rosa-Neto P. (2011). Case Studies in Dementia: Common and Uncommon Presentations, , 322.

Gauthier S., Rosa-Neto P., Soucy J. P., Leonardo G. (2011). Case of a young man smoking pot but with a mother who died of dementia, , 188-192.

Gillette-Guyonnet S., Andrieu S., Nourhashemi F., Gardette V., Coley N., Cantet C., Gauthier S., Ousset P. J., Vellas B. (2011). Long-term progression of Alzheimer's disease in patients under antidementia drugs, Alzheimers Dement, 7(6), 579-92. En savoir plus.

Holthoff V.A., Ferris S., Ihl R., Robert P., Winblad B., Gauthier S., Sternberg K., Tennigkeit F. (2011). Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice, Alzheimers Res Ther, 3(5), 27. En savoir plus.

Ihl R., Frolich L., Winblad B., Schneider L., Burns A., Moller H. J., Gauthier S. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias, World J Biol Psychiatry, 12(1), 2-32. En savoir plus.

Jones R., Wilkinson D., Lopez O. L., Cummings J., Waldemar G., Zhang R., Mackell J., Gauthier S. (2011). Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease, Trials, 12, 233. En savoir plus.

Massoud F., Desmarais J.E., Gauthier S. (2011). Switching cholinesterase inhibitors in older adults with dementia, Int Psychogeriatr, 23(3), 372-378. En savoir plus.

Poirier J., Gauthier S. (2011). La Maladie D’Alzheimer: Le Guide , .

Vellas B., Aisen P.S., Sampaio C., Carrillo M., Scheltens P., Scherrer B., Frisoni G.B., Weiner M., Schneider L., Gauthier S., Wied C.C., Hendrix S., Feldman H., Cedarbaum J., Petersen R., Siemers E., Andrieu S., Prvulovic D., Touchon J., Hampel H. (2011). Prevention trials in Alzheimer's disease: An EU-US task force report, Prog Neurobiol. En savoir plus.

Villeneuve S., Massoud F., Bocti C., Gauthier S., Belleville S. (2011). The nature of episodic memory deficits in MCI with and without vascular burden, Neuropsychologia, 49(11), 3027-35. En savoir plus.

Waldemar G., Gauthier S., Jones R., Wilkinson D., Cummings J., Lopez O., Zhang R., Xu Y., Sun Y., Knox S., Richardson S., Mackell J. (2011). Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease, Int J Geriatr Psychiatry, 26(2), 150-157. En savoir plus.

Wu L., Rosa-Neto P., Gauthier S. (2011). Use of biomarkers in clinical trials of Alzheimer disease: from concept to application, Mol Diagn Ther, 15(6), 313-25. En savoir plus.